+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Forecast 2024-2030- Product Image
Global Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Forecast 2024-2030- Product Image
Sale

Global Cocaine Use Disorder Market by Therapeutic Approaches (Behavioral Therapies, Cognitive-Behavioral Therapy, Contingency Management), Medications (Anticonvulsants, Antidepressants, Antipsychotics), Treatment Setting - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967619
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cocaine Use Disorder Market size was estimated at USD 1.32 billion in 2023, USD 1.39 billion in 2024, and is expected to grow at a CAGR of 6.21% to reach USD 2.01 billion by 2030.

The market for cocaine use disorder includes a wide range of medical treatments, rehabilitation programs, therapy sessions, and support systems aimed at individuals suffering from cocaine dependence. The increased awareness and social acceptance of addiction issues are necessitating the treatments for cocaine use disorders. The governmental and private funding for addiction treatment programs influences the market scope. The advancements in treatment methodologies and the growing prevalence of cocaine use worldwide are also enhancing the adoption of cocaine use disorder treatments.

However, the limited availability of specialized healthcare providers and social stigmas associated with drug addiction may limit the adoption of treatment options. Regulatory hurdles and variability in treatment effectiveness across populations also pose significant challenges for market growth. Moreover, personalized medicine approaches utilizing genetic and psychosocial markers to tailor treatments generate significant growth potential. The application of artificial intelligence and machine learning in predicting treatment outcomes and enhancing patient engagement through digital platforms also creates significant opportunities for market expansion.

Regional Insights

In the Americas region, cocaine remains a significant public health concern, with considerable investments into research on novel treatments and rehabilitation programs. The demand for effective treatment options underscores the urgent consumer need for support in managing cocaine use disorder in the United States and Canada. Recent patents in the Americas region have highlighted innovative therapeutic approaches, including pharmacological interventions and digital health solutions designed to curb addiction. The European Union countries demonstrate a varied spectrum of cocaine use patterns, from high prevalence rates in nightlife settings to more contained use in broader populations.

Significant efforts are being made to unify data collection and reporting standards across the EMEA region to better address consumer needs. Initiatives to tackle cocaine use are in nascent stages in the Middle East and Africa region, often integrated within broader drug misuse prevention programs. In the APAC region, Major countries such as China, India, and Japan enacted strict drug enforcement policies and are investing in public education campaigns to deter substance use. Research into the nature of drug addiction and its treatment is growing in APAC countries, reflecting a burgeoning awareness of the need for evidence-based interventions in the management of cocaine use disorder.

Market Trends by Segment

  • Treatment Setting: Increasing preference for residential rehabilitation facilities
  • Medications: Need based preference for psychostimulants for treatment of cocaine use disorder

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

​​Scientists Develop a Vaccine For Cocaine

In a groundbreaking initiative, Brazilian scientists have developed Calixcoca, a novel vaccine aimed at combating cocaine and crack addiction by inhibiting the euphoric effects traditionally associated with these substances. This innovative approach has shown substantial efficacy in animal trials, generating significant levels of cocaine-binding antibodies with minimal side effects, and even providing potential protection to the fetuses of pregnant addicts. The treatment is viewed as a standalone cure and acts rather as a supplementary measure to traditional rehabilitation efforts, catering to recovering addicts committed to maintaining their sobriety.

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

The U.S. Food and Drug Administration approved Brixadi, a buprenorphine extended-release injection, as a treatment for moderate to severe opioid use disorder (OUD). This approval introduces new dosing formats: weekly and monthly subcutaneous injections, tailored for individuals either initiating treatment with a transmucosal buprenorphine product or already under buprenorphine treatment.

Key Company Profiles

The report delves into recent significant developments in the Cocaine Use Disorder Market, highlighting leading vendors and their innovative profiles. These include Alkermes PLC, Alnylam Pharmaceuticals, Inc., Camurus AB, Indivior PLC, Johnson & Johnson Services, Inc., KemPharm, Inc., Novartis International AG, Orexo AB, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Revive Therapeutics Ltd., Sage Therapeutics, Inc., Shionogi & Co., Ltd., Teva Pharmaceuticals USA, Inc., and Viatris Inc.

This research report offers invaluable insights into various crucial aspects of the Cocaine Use Disorder Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cocaine use worldwide
5.1.1.2. Increasing awareness and social acceptance of addiction issues, necessitating the treatments for cocaine use disorders
5.1.1.3. Governmental and private funding for addiction treatment programs
5.1.2. Restraints
5.1.2.1. Limited availability of specialized healthcare providers and social stigmas associated with cocaine addiction
5.1.3. Opportunities
5.1.3.1. Innovative medicine approaches utilizing genetic and psychosocial markers to tailor personalized treatments
5.1.3.2. Application of artificial intelligence and machine learning in predicting treatment outcomes and enhancements in patient engagement through digital platforms
5.1.4. Challenges
5.1.4.1. Regulatory hurdles and variability in treatment effectiveness across populations worldwide
5.2. Market Segmentation Analysis
5.2.1. Treatment Setting: Increasing preference for residential rehabilitation facilities
5.2.2. Medications: Need based preference for psychostimulants for treatment of cocaine use disorder
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cocaine Use Disorder Market, by Therapeutic Approaches
6.1. Introduction
6.2. Behavioral Therapies
6.3. Cognitive-Behavioral Therapy
6.4. Contingency Management
6.5. Medication-Assisted Treatment
6.6. Motivational Enhancement
7. Cocaine Use Disorder Market, by Medications
7.1. Introduction
7.2. Anticonvulsants
7.3. Antidepressants
7.4. Antipsychotics
7.5. Psychostimulants
8. Cocaine Use Disorder Market, by Treatment Setting
8.1. Introduction
8.2. Hospital-Based Treatment Programs
8.3. Inpatient Rehabilitation Centers
8.4. Outpatient Rehabilitation Centers
8.5. Residential Rehabilitation Facilities
9. Americas Cocaine Use Disorder Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cocaine Use Disorder Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cocaine Use Disorder Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. ??Scientists Develop a Vaccine For Cocaine
12.3.2. FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. COCAINE USE DISORDER MARKET RESEARCH PROCESS
FIGURE 2. COCAINE USE DISORDER MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COCAINE USE DISORDER MARKET DYNAMICS
FIGURE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2030 (%)
FIGURE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2030 (%)
FIGURE 12. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COCAINE USE DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL COCAINE USE DISORDER MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COGNITIVE-BEHAVIORAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY COGNITIVE-BEHAVIORAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY CONTINGENCY MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY CONTINGENCY MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATION-ASSISTED TREATMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATION-ASSISTED TREATMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY HOSPITAL-BASED TREATMENT PROGRAMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY HOSPITAL-BASED TREATMENT PROGRAMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY INPATIENT REHABILITATION CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY OUTPATIENT REHABILITATION CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY RESIDENTIAL REHABILITATION FACILITIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL COCAINE USE DISORDER MARKET SIZE, BY RESIDENTIAL REHABILITATION FACILITIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 59. CANADA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 60. CANADA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 61. CANADA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 62. CANADA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 63. CANADA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 64. CANADA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 65. MEXICO COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 66. MEXICO COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 67. MEXICO COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 68. MEXICO COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 69. MEXICO COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 70. MEXICO COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES COCAINE USE DISORDER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 93. CHINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 94. CHINA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 95. CHINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 96. CHINA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 97. CHINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 98. CHINA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 99. INDIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 100. INDIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 101. INDIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 102. INDIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 103. INDIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 104. INDIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 111. JAPAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 112. JAPAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 113. JAPAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 114. JAPAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 115. JAPAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 116. JAPAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 147. THAILAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 148. THAILAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 149. THAILAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 150. THAILAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 151. THAILAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 152. THAILAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA COCAINE USE DISORDER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 167. DENMARK COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 168. DENMARK COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 169. DENMARK COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 170. DENMARK COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 171. DENMARK COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 172. DENMARK COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 173. EGYPT COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 174. EGYPT COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 175. EGYPT COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 176. EGYPT COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 177. EGYPT COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 178. EGYPT COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 179. FINLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 180. FINLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 181. FINLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 182. FINLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 183. FINLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 184. FINLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 185. FRANCE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 186. FRANCE COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 187. FRANCE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 188. FRANCE COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 189. FRANCE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 190. FRANCE COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 191. GERMANY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 192. GERMANY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 193. GERMANY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 194. GERMANY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 195. GERMANY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 196. GERMANY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 203. ITALY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 204. ITALY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 205. ITALY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 206. ITALY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 207. ITALY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 208. ITALY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 221. NORWAY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 222. NORWAY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 223. NORWAY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 224. NORWAY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 225. NORWAY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 226. NORWAY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 227. POLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 228. POLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 229. POLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 230. POLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 231. POLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 232. POLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 233. QATAR COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 234. QATAR COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 235. QATAR COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 236. QATAR COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 237. QATAR COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 238. QATAR COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 257. SPAIN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 258. SPAIN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 259. SPAIN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 260. SPAIN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 261. SPAIN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 262. SPAIN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 267. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 268. SWEDEN COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 273. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 274. SWITZERLAND COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 275. TURKEY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 276. TURKEY COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 277. TURKEY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 278. TURKEY COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 279. TURKEY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 280. TURKEY COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY THERAPEUTIC APPROACHES, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2018-2023 (USD MILLION)
TABLE 292. UNITED KINGDOM COCAINE USE DISORDER MARKET SIZE, BY TREATMENT SETTING, 2024-2030 (USD MILLION)
TABLE 293. COCAINE USE DISORDER MARKET SHARE, BY KEY PLAYER, 2023
TABLE 294. COCAINE USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Alkermes PLC
  • Alnylam Pharmaceuticals, Inc.
  • Camurus AB
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • KemPharm, Inc.
  • Novartis International AG
  • Orexo AB
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Revive Therapeutics Ltd.
  • Sage Therapeutics, Inc.
  • Shionogi & Co., Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.01 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Cocaine Intoxication - Epidemiology Forecast - 2034 - Product Image

Cocaine Intoxication - Epidemiology Forecast - 2034

  • Report
  • 47 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2024 - Product Image

Cocaine Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • 50 Pages
  • Global
From
Addiction Medicine. Science and Practice. Edition No. 2 - Product Image

Addiction Medicine. Science and Practice. Edition No. 2

  • Book
Neuroscience of Alcohol. Mechanisms and Treatment - Product Image

Neuroscience of Alcohol. Mechanisms and Treatment

  • Book
Addictions Therapeutics Global Market Report 2024 - Product Image

Addictions Therapeutics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.